Overview of Guidelines for the Medical Treatment of Acute Kawasaki Disease in Japan (2020 Revised Version) and Positioning of Plasma Exchange Therapy in the Acute Phase
Author:
Affiliation:
1. Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
2. Department of Pediatrics, Saitama Medical Center, Dokkyo Medical University, Saitama, Japan.
Abstract
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health
Reference27 articles.
1. Guidelines for medical treatment of acute Kawasaki disease. (in Japanese).;Pediatr Cardiol Card Surg,2003
2. Guidelines for medical treatment of acute Kawasaki disease (2012 revised version).;Pediatr Int,2014
3. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.;Kobayashi;Lancet,2012
4. Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial.;Mori;Sci Rep,2018
5. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.;Hamada;Lancet,2019
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Necrotic Change of Tunica Media Plays a Key Role in the Development of Coronary Artery Lesions in Kawasaki Disease;Circulation Journal;2024-08-06
2. Serum NLRP3: A potential marker for identifying high-risk coronary arterial aneurysm in children with Kawasaki disease;Cytokine;2024-08
3. Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial;American Heart Journal;2024-07
4. Prediction Models for Intravenous Immunoglobulin Non-Responders of Kawasaki Disease Using Machine Learning;Clinical Drug Investigation;2024-06
5. Diagnostic Conundrum: Fever and Pyuria Preceding Diagnosis of Kawasaki Disease in Children;Pediatric Infection & Vaccine;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3